The X Posts
An info-share progression from stocktwits to X to substack.
Organic growth: unicellular (day to day posts on stocktwits) to multicellular (more refined, structured posts on X but still random) to detailed articles on substack (purposeful, organized, productive). Here are the core posts on X, covering an array of topics in no particular order other than posting date. Many of these posts formed the basis for 2 - The Killer Nobody Names which calls out inflammation from its many hiding places.
1 Three of Five detailed

2 How Gohibic works

3 Vilo not being used in US ICUs


4 NIH not supporting Vilo

5 Vilo in PG, effect on other organs


6 The value of this biotech



7 Big green events


8 That much potential


9 Fallacy post


10 NLR and disease severity


11 Living on Venus


12 CDC Nov 22 report


13 Executive summary, good/bad



14 Executive summary, NFL



15 Repost of #2



16 Long-standing truth


17 Days and deaths


18 This much potential



19 Dead lungs



20 Organ damage we see and don’t





21 Lack of inflammation policy


22 Vehicle-alcohol analogy


23 Inflammation with ChatGPT


24 Ten days on from post 17


25 Live Web Event



26 Don’t Flush DOWN




27 We are nature

28 6.8 million likes


29 Predictable and Preventable


30 Sepsis to amputation


31 C5a as center of inflammation


32 Vilo sales potential



33 Instinctive humans




34 Heart disease


35 Wainwright’s calculator



36 C5a-C5aR axis of value



37 IFN production


38 Inflammation episode 1


39 Inflammation episode 2



40 Happy World Encephalitis Day


41 Vilo is very important



42 Retail, buy in confidence



43 IFRX absurdly priced


44 IFRX for the win



45 Vitamin D and covid



46 Odds of dying


47 ICU through sodium


48 Nephrons and inflammation


49 What are you waiting for


50 Neurological disorders


51 Seventh annual sepsis alliance


52 Q4 2023, how many saved


53 Grandma needlessly died


54 Death by viral sepsis


55 Vilo treating influenza


56 Predicting pandemics


57 HS, INF904, and m-HiSCR




58 Dr. Zychlinsky’s NETs


59 Practical and essential defense



60 Vilo, before it’s too late


61 Viral vascular injury



62 Not so smart Vilo mcap


63 Not so beautiful fractals


64 Animal cruelty, human catastrophe


65 PG sales first year




66 An immunocentric, global problem


67 INF904 for CoV CKD patients



68 Don’t stress over inflammation



69 No Vilo: ignorance or negligence


70 Methods of controlling inflammation


71 Plant-based milk for the win
72 GPT-4 C5a-C5aR biotech valuation



73 Vilo need in the US and EU


74 The C5a/R global market is BIG!


75 Canada and the good fight


76 Top 10 HxNx pandemic threats


77 INF904 R&D event summary





78 What motivates InflaRx biotech


79 Jokes about C5a-C5aR signaling


80 H5N1 contaminated product risk




81 Viral sepsis from many sources



82 BARDA ARDS study with Vilo



83 Sepsis and ARDS



84 No more mopping up floors



85 Controlling the neutrophil tap



86 Feed and trust your gut


87 The fountain of demise


88 The immune system as a work of art



89 Sepsis and Inflammation orgs unite


90 Know the cause of death



91 Behave, Klebsiella pneumoniae


92 Death by ignorance


93 Better health through better leadership


94 ST discussions, a point in time


95 Better health through better leadership #2



96 Gohibic is cost effective



97 Covid deaths, a point in time


98 Me and my 50 healthcare friends


99 A vital 2-step process


100 A refined 2-step process



101 Summer of ’25…or 26


102 Options for step 2 are very much lacking


103 Death by ARDS



104 The enemy: H1N1





105 Nature will take care of size reductions


106 We should use all tools made available



107 A bad case of PG


108 Vilo in PG?



109 Not acceptable leadership


110 Vilo/904 presentations, a point in time


111 Finding the right treatment takes decades


112 Paradigm-level anti-inflammatory therapy


113 Bye-bye draining tunnels




114 Hashtag common sense healthcare



115 Stay ahead of the curve


116 Neutrophil hyperactivity and tunnels



117 PG is a neutrophilic dermatosis



118 Nu.Q® NETs, as a marker of NETosis



119 Three diseases most doctors can’t spell




120 IgA nephropathy, a story



